-
Generic Oral Medicine for MS-Related Walking Issues Now Available in US
Read about Mylan’s U.S. launch of dalfampridine ER tablets, the authorized generic version of Ampyra, for MS patients with walking difficulties.
Click here to find out more about this.
What do you think of this news? Is this medication part of your treatment plan?
Log in to reply.